Quantcast
Last updated on April 18, 2014 at 15:02 EDT

Latest Stephen L. DeFelice Stories

2013-05-23 08:28:35

WESTFIELD, N.J., May 23, 2013 /PRNewswire-USNewswire/ -- Stephen L. DeFelice, M.D., Founder and Chairman of FIM, The Foundation for Innovation in Medicine, released a new video criticizing mainstream health care cost projections of Medicare, Medicaid and Obamacare, among others, because they omit the discovery of cures. He cites a boom in technology, including gene modification and new organ growth as inevitable in curing many of our major costly diseases. (To view the video and additional...

2013-03-25 08:27:40

FAIRFIELD, N.J., March 25, 2013 /PRNewswire/ -- Dr. Stephen L. DeFelice of Westfield, NJ, was awarded the 2013 UNICO National Marconi Science Award by UNICO National President David Donnini at a gala award ceremony attended by UNICO National officers and dignitaries from across the country during UNICO's Board of Directors meeting in Las Vegas, NV. (Photo: http://photos.prnewswire.com/prnh/20130325/PH82207) Dr. DeFelice, an accomplished researcher, physician, author and advocate,...

2012-10-02 06:26:25

MOUNTAINSIDE, N.J., Oct. 2, 2012 /PRNewswire/ -- The physician chairman of the well-established non-profit group, FIM, the Foundation for Innovation in Medicine, appealed in a letter to Mitt Romney to back a unique plan to reduce health care costs by speeding up medical discovery. Stephen L. DeFelice, said in his letter, "No matter how you toss the coin, current policies and future plans will ultimately ration pharmaceuticals, medical devices and hospitalization as well as decrease physician...

2010-01-29 13:12:00

JOHNSTOWN, Pa., Jan. 29 /PRNewswire-FirstCall/ -- EP Global Communications, Inc. (EPGL), (the Company), (Pink Sheets: EPGL), (www.eparent.com), the parent company of Exceptional Parent (EP) magazine, is proud to announce that Stephen L. DeFelice, MD, has joined the EPGL Advisory Board. Dr. DeFelice is one of the world's leading authorities on nutraceutical products and is credited for introducing the term "nutraceutical." "This addition to our team of experts will enable EPGL to more...